The hype is loud and the money is flowing. But inside healthcare, clinicians wonder if the tech is just a larger-scale rehash ...

A single pill that includes low doses of three different antihypertensives reduces recurrent stroke by approximately 40% in ...

NICE recommendation of darolutamide plus hormone therapy for metastatic prostate cancer offers around 6000 patients in ...

Using semaglutide or tirzepatide for less than 2 years can cost as much as a Roux-en-Y gastric bypass — a one-time procedure ...

Onset of diabetes before age 40 is associated with 2.5 times higher risk for mortality than onset at a later age.

A recent federal opinion offers doctors new latitude to invest in healthcare ventures, but financial entanglements can still ...

Deaths from acute respiratory distress syndrome (ARDS) and sepsis spiked in the US during the COVID pandemic, and ...

Patients with chemorefractory metastatic colorectal cancer derive no overall survival benefit from giving anti-EGFR ...

MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...

A new study suggests nitrous oxide may offer a new treatment option for older adults with treatment-resistant depression.

The published dosing standards set the drug-delivery technology on a path toward FDA consideration and eventual use against ...

Sirona, an oral gastro-retentive hydrogel, offers a safe, feasible nonpharmacologic approach for weight loss with reduced ...